The FDA has approved Prevnar 20, a Pfizer vaccine that protects against 20 pneumococcal strains—seven more than the company’s blockbuster Prevnar 13. But others are on the big pharma company’s heels with vaccine candidates that aim to match or even beat the Pfizer pneumococcal vaccines.